Last reviewed · How we verify
NCT03350269
Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates
NA trial testing Information provision in Kidney Failure in 1,310 participants. Terminated before completion.
17 June 2020
Quick facts
| Lead sponsor | Arbor Research Collaborative for Health |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 1,310 |
| Start date | 15 November 2017 |
| Primary completion | 17 June 2020 |
| Estimated completion | 20 October 2020 |
| Sites | 6 locations across United States |
Drugs / interventions tested
- Information provision
Conditions studied
- Kidney Failure — all drugs for Kidney Failure →
- Surgery — all drugs for Surgery →
- Renal Failure — all drugs for Renal Failure →
Sponsor
Arbor Research Collaborative for Health
Who can join
18 and older, any sex, with Kidney Failure or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is designed as a randomized controlled trial. The investigators hypothesize that kidney transplant recipient candidates whose donors are offered reimbursement of lost wages (treatment arm) will have a higher probability of receiving a living donor kidney transplant than those randomized to no offer of lost wage reimbursement (control arm). The study expects to demonstrate incremental living donor kidney transplants by assisting individuals who wish to be living organ donors but would be otherwise unable to do so due to the obligatory forfeit of income during the evaluation, donation surgery, and post-operative recuperation periods.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03350269
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Information provision
Trials testing the same drug.
- NCT04917822 — Project KING: To Strengthen Parent-child Relationship and Adaptation · NA · completed
- NCT03144336 — Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention · NA · completed
Other recruiting trials for Kidney Failure
Currently open trials in the same condition.
- NCT07492511 — Renal and Hepatic Abnormal Doppler Patterns in Trauma · recruiting
- NCT06243731 — A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation · recruiting
- NCT06642597 — STarting incrEmental Prescription of Peritoneal Dialysis · NA · recruiting
- NCT06343727 — A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) · NA · recruiting
- NCT07053462 — CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk · Phase 1, PHASE2 · recruiting
Other Arbor Research Collaborative for Health trials
Trials by the same sponsor.
- NCT05272319 — Genetic Collection Protocol · recruiting
- NCT04181138 — Primary Sclerosing Cholangitis in Children · recruiting
- NCT04970056 — Pancreatic Cancer Early Detection Consortium · recruiting
- NCT03808038 — Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study · completed
- NCT02922751 — FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03350269 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arbor Research Collaborative for Health
- Last refreshed: 3 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03350269.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing